The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.
Also called NCT02998229
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 300 participants
- Registry
-
NCT02998229
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT02998229. Allocation not applicable; no masking; primary purpose treatment. Start 2024-04-16 (actual); primary completion 2027-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
- Acronym
- ARTISSE
- Condition
- Intracranial Aneurysm
- Intervention (Device)
- Artisse™ Intrasaccular Device
- Lead sponsor
- Medtronic Neurovascular Clinical Affairs
Record details
- Record id
cardio:ct-nct02998229- Content hash
43b50a8a5fce7bc8add5517d120f86e38c86285a83ef580afe51b2566fc2e2b2